Puma Biotechnology Inc

Today, PBYI trades at 8.44 USD.

For broader market analysis, dive into the technicals on the Puma Biotechnology Inc stock price chart and read the latest PBYI news:
– Weekly Recap: Higher 2026 guidance and ALISCA-Lung2 trial begins
– Puma Biotechnology Q3 Earnings Call Highlights
– PBYI: Higher FY26 income guidance and rising NERLYNX demand offset lower China royalties

Markets don't sleep, here's what's going on with PBYI at the moment:
– Weekly Recap: Higher 2026 guidance and ALISCA-Lung2 trial begins
– Puma Biotechnology Q3 Earnings Call Highlights
– PBYI: Higher FY26 income guidance and rising NERLYNX demand offset lower China royalties

See more updates in real-time with our News Flow.

Puma Biotechnology Inc is scheduled to release its next earnings report on Mar 4, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts

PBYI stock is 5.68% volatile and has beta coefficient of 1.14.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like PBYI are typically less volatile than smaller companies

Track every detail on Puma Biotechnology Inc stock chart and check out the list of the most volatile stocks — is Puma Biotechnology Inc there?

To understand the PBYI stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −1.45%
– 1 week — −22.28%
– 1 month — −18.37%

PBYI all-time low was 1.60 USD (May 11, 2022), and its highest price is 279.37 USD (Aug 26, 2014). Find more dynamics in the Stock Heatmap and on the Puma Biotechnology Inc stock chart.

Puma Biotechnology Inc market capitalization is ‪425.87 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Puma Biotechnology Inc stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Puma Biotechnology Inc stacks up against other companies

The safest way to buy Puma Biotechnology Inc stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade PBYI directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.

Investing in Puma Biotechnology Inc depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Puma Biotechnology Inc financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our PBYI technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — buy

Combine fundamental and technical analysis for better results.

Puma Biotechnology Inc stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Puma Biotechnology Inc stocks trade under the symbol PBYI.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.

PBYI earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.04 USD, resulting in a 300.00% surprise. The estimated earnings for the next quarter are 0.09 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Puma Biotechnology Inc financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk

Puma Biotechnology Inc revenue for the last quarter amounts to ‪56.50 M‬ USD despite the estimated figure of ‪53.00 M‬ USD. In the next quarter revenue is expected to reach ‪57.50 M‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Puma Biotechnology Inc financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses

Yes, you can track Puma Biotechnology Inc financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.

PBYI net income for the last quarter is ‪6.00 M‬ USD, while the quarter before that showed ‪8.19 M‬ USD of net income which accounts for −26.73% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Puma Biotechnology Inc financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control

No, Puma Biotechnology Inc does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends